sns insider pvt ltd.png
Medical Isotope Market to Reach USD 12.15 Billion by 2032, Driven by Increased Demand in Cancer Treatment and Diagnostic Advancements | Research by SNS Insider
08 déc. 2024 08h00 HE | SNS Insider pvt ltd
Austin, United States, Dec. 08, 2024 (GLOBE NEWSWIRE) -- Medical Isotope Market Size & Growth Analysis: “According to SNS Insider, The Global Medical Isotope Market was valued at USD 5.66...
83970_USNuclearCorpLogo.jpg
US Nuclear’s Medical Isotope Production to Revolutionize Healthcare
30 janv. 2024 08h30 HE | US Nuclear Corp.
LOS ANGELES, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –One of the most critical problems faced by the healthcare industry worldwide is the severe shortage of radionuclides for nuclear...
log.png
TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a Cancer-Fighting Medical Isotope
16 déc. 2020 09h00 HE | TRIUMF Innovations
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) -- TRIUMF, Canada’s particle accelerator centre, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals...
artms_logo_rgb_Jan2017 150dpi.png
ARTMS Announces New Appointments to Executive Leadership Team
02 sept. 2020 08h30 HE | ARTMS Products Inc.
VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) -- ARTMS Inc. (ARTMS), the global leader in the development and commercialization of technologies that are transforming the production of...
artms_logo_rgb_Jan2017 150dpi.png
ARTMS and Telix Pharmaceuticals Announce Manufacturing Collaboration
06 mai 2020 09h00 HE | ARTMS Products Inc.
VANCOUVER, British Columbia and MELBOURNE, Australia, May 06, 2020 (GLOBE NEWSWIRE) -- ARTMS Products Inc. (ARTMS), a global leader in the development of novel technologies enabling the production...
ph.png
Phoenix and SHINE Achieve New World Record for Strongest Nuclear Fusion Reaction in a Steady-State System
02 oct. 2019 08h00 HE | Phoenix; SHINE Medical Technologies LLC
Leading nuclear technology companies collaborating to help turn nuclear weapons into medicine and help a billion patients Breakthrough has potential to transform medical isotope production, solve a...
UCLE
Us Nuclear Corp to Become Miftec’s Exclusive Manufacturer of New Medical Isotope Generators
07 déc. 2017 13h25 HE | US Nuclear Corp.
LOS ANGELES, CA, Dec. 07, 2017 (GLOBE NEWSWIRE) -- US Nuclear Corp (OTCBB: UCLE) has signed a letter of intent with MIFTEC to become the exclusive contractor to manufacture medical isotope...